FDA issues warning on insulin pump cybersecurity weakness
The MiniMed 508 and MiniMed Paradigm series insulin pumps are being recalled because of potential cybersecurity risks; 4,000 patients in the...
Aspirin shows little benefit for primary prevention of vascular disease in diabetes
Is aspirin for primary prevention of cardiovascular events in patients with diabetes worth the risk of adverse bleeding events?
SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF
NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart...
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.
ICU admissions raise chronic condition risk
Compared to non-ICU visitors, patients had greater risk of developing new chronic conditions after discharge.
SGLT2 inhibitors morph into HF drugs
Intensive insulin added no benefit for hyperglycemia after ischemic stroke
Results from a large RCT showed intensive and standard insulin regimens produced similar clinical outcomes after an acute ischemic stroke.
Metformin associated with acidosis only in patients with eGFR 30 mL/min per 1.73 m 2
Does metformin increase the risk of lactic acidosis in chronic kidney disease (CKD)?
SGLT-2 inhibitors promising for heart failure prevention, not treatment
LOS ANGELES – The combination of heart failure and diabetes is particularly lethal.
New diabetes drugs solidify their cardiovascular and renal benefits